Malley Thomas bought KNSA
August 14, 2025 · Form 4 insider transaction
Malley Thomas bought 18,760 shares of Kiniksa Pharmaceuticals International, plc at $15.47 per share, a transaction worth $290.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,760
Price
$15.47
Total value
$290.2K
InsiderMalley Thomas
RoleDirector
SecurityClass A Ordinary Shares
Transaction codeM: Option exercise
Transaction dateAugust 14, 2025
Filing dateAugust 14, 2025
Shares owned after31,306
OwnershipDirect
10b5-1 planNo
AmendedNo